{"type":"rich","version":"1.0","title":"D.A. Wallach Explains Why Biotech VC Is So Different","author_name":"Odd Lots","author_url":"https://bloomberg.com/podcasts/odd_lots","provider_name":"Omny Studio","provider_url":"https://omny.fm","html":"<iframe src=\"https://omny.fm/shows/odd-lots/d-a-wallach-explains-why-biotech-vc-is-so-different/embed\" width=\"100%\" height=\"180\" allow=\"autoplay; clipboard-write; fullscreen\" allowfullscreen frameborder=\"0\" title=\"D.A. Wallach Explains Why Biotech VC Is So Different\"></iframe>","width":600,"height":180}